TTAB Greenlights Boehringer's 'Breathless' Trademark
The Trademark Trial and Appeal Board on Monday ruled that drugmaker Boehringer Ingelheim Pharmaceuticals Inc. can register "breathless" as a trademark for promoting awareness about a rare fatal lung disorder, overturning...To view the full article, register now.
Already a subscriber? Click here to view full article